Literature DB >> 16819253

Pulmonary infarction as the initial manifestation of Takayasu's arteritis.

Tomomi Nakamura1, Shinichiro Hayashi, Mami Fukuoka, Naoko Sueoka, Kohei Nagasawa.   

Abstract

A 50-year-old woman reporting sudden-onset chest pain was diagnosed as having pulmonary infarction associated with Takayasus arteritis. She had experienced moderate malaise and cough for 3 months. Computed tomography (CT) and magnetic resonance imaging (MRI) showed wedge-shaped infiltrative shadows typical of pulmonary infarction in the right lung. Although pulmonary artery involvement in Takayasus arteritis is well documented, most patients show only signs of mild to moderate pulmonary hypertension. Few reports discuss patients with symptoms due to pulmonary infarction as the initial manifestation. Takayasus arteritis should therefore be considered a differential diagnosis in pulmonary infarction.

Entities:  

Mesh:

Year:  2006        PMID: 16819253     DOI: 10.2169/internalmedicine.45.1686

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Nontuberculous mycobacterial disease concomitant with a pulmonary artery occlusion caused by Takayasu's arteritis.

Authors:  Tomoshi Sugiyama; Koji Kawaguchi; Noriyasu Usami; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-10-21

2.  Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China.

Authors:  Xiufang Kong; Lili Ma; Peng Lv; Xiaomeng Cui; Rongyi Chen; Zongfei Ji; Huiyong Chen; Jiang Lin; Lindi Jiang
Journal:  Arthritis Res Ther       Date:  2020-06-05       Impact factor: 5.156

3.  Pulmonary artery involvement in Takayasu's arteritis: diagnosis before pulmonary hypertension.

Authors:  Jing Yang; Min Peng; Juhong Shi; Wenjie Zheng; Xuezhong Yu
Journal:  BMC Pulm Med       Date:  2019-11-27       Impact factor: 3.317

4.  The clinical features of pulmonary artery involvement in Takayasu arteritis and its relationship with ischemic heart diseases and infection.

Authors:  Hiroki Mukoyama; Mirei Shirakashi; Nozomi Tanaka; Takeshi Iwasaki; Toshiki Nakajima; Hideo Onizawa; Hideaki Tsuji; Koji Kitagori; Shuji Akizuki; Ran Nakashima; Kosaku Murakami; Masao Tanaka; Akio Morinobu; Hajime Yoshifuji
Journal:  Arthritis Res Ther       Date:  2021-12-03       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.